A new family of enzymes enables precise cuts in single-stranded DNA, offering powerful new tools for genetic engineering and ...

Plant biotechnology uses tools like genetic modification and bioengineering to enhance crops’ resilience, nutritional value, ...

Colossal’s dire wolf project is not a resurrection – it is an imitation. But that doesn’t mean it lacks value. It offers a ...

Colossal Biosciences achieves a scientific breakthrough. They bring back the dire wolf from extinction. Using genetic ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at whereGenmab A/S (NASDAQ:GMAB) stands against other most profitable ...

Dear reader, space exploration stands as one of the greatest challenges of our modern era. Scientists and engineers are ...

Because biotech involves expensive R&D and clinical testing, it is susceptible to shifting rate patterns. According to Genetic Engineering and Biotechnology News, lower rates increase the amount ...

Dallas-based biotech company Colossal has announced ... In this light, the project represents a remarkable demonstration of genetic engineering, rather than a literal revival of an extinct species.

Tom Brady, an investor in Colossal Biosciences, celebrates the company's groundbreaking achievement in de-extinction. Colossal successfully revived th ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

Colossal Biosciences has announced the "resurgence" of the dire wolf, a species believed to have vanished from the Earth13,000 years ago.